Previous Article | Next Article 
Journal of Virology, February 2002, p. 998-1003, Vol. 76, No. 3
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.76.3.998-1003.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Phosphorylation of the Epstein-Barr Virus (EBV) DNA Polymerase Processivity Factor EA-D by the EBV-Encoded Protein Kinase and Effects of the L-Riboside Benzimidazole 1263W94
Edward Gershburg1 and Joseph S. Pagano1,2,3*
Lineberger Comprehensive Cancer Center,1
Departments of Medicine,2
Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 275993
Received 9 August 2001/
Accepted 19 October 2001
A member of the family of L-riboside benzimidazole compounds, 1263W94, was shown recently to inhibit replication of Epstein-Barr virus (EBV) (V. L. Zacny, E. Gershburg, M. G. Davis, K. K. Biron, and J. S. Pagano, J. Virol. 73:72717277, 1999). In the present report the effect of 1263W94 on the phosphorylation pattern of the EBV DNA polymerase processivity factor, EA-D, during viral reactivation in latently EBV-infected Akata cells is analyzed. This pattern specifically changes with progression of cytolytic infection. In the presence of 1263W94 the appearance of the hyperphosphorylated form of EA-D is mainly affected. Next, coexpression of the cloned EBV-encoded protein kinase (EBV PK), BGLF4, with EA-D demonstrated the ability of EBV PK to phosphorylate EA-D to its hyperphosphorylated form in transient assays. However, the phosphorylation of EA-D was not directly inhibited by 1263W94 in these coexpression assays. The results indicate that the EBV PK appears to be responsible for the hyperphosphorylation of EA-D, imply that the phosphorylation status of EA-D is important for viral replication, and suggest that 1263W94 acts at a level other than direct inhibition of EA-D phosphorylation by EBV PK.
* Corresponding author. Mailing address: Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, CB# 7295, Chapel Hill, NC 27599-7295. Phone: (919) 966-1183. Fax: (919) 966-9673. E-mail:
Joseph_Pagano{at}med.unc.edu.
Journal of Virology, February 2002, p. 998-1003, Vol. 76, No. 3
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.76.3.998-1003.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Asai, R., Kato, A., Kawaguchi, Y.
(2009). Epstein-Barr virus protein kinase BGLF4 interacts with viral transactivator BZLF1 and regulates its transactivation activity. J. Gen. Virol.
90: 1575-1581
[Abstract]
[Full Text]
-
Zhu, J., Liao, G., Shan, L., Zhang, J., Chen, M.-R., Hayward, G. S., Hayward, S. D., Desai, P., Zhu, H.
(2009). Protein Array Identification of Substrates of the Epstein-Barr Virus Protein Kinase BGLF4. J. Virol.
83: 5219-5231
[Abstract]
[Full Text]
-
Prichard, M. N., Sztul, E., Daily, S. L., Perry, A. L., Frederick, S. L., Gill, R. B., Hartline, C. B., Streblow, D. N., Varnum, S. M., Smith, R. D., Kern, E. R.
(2008). Human Cytomegalovirus UL97 Kinase Activity Is Required for the Hyperphosphorylation of Retinoblastoma Protein and Inhibits the Formation of Nuclear Aggresomes. J. Virol.
82: 5054-5067
[Abstract]
[Full Text]
-
Yang, P.-W., Chang, S.-S., Tsai, C.-H., Chao, Y.-H., Chen, M.-R.
(2008). Effect of phosphorylation on the transactivation activity of Epstein-Barr virus BMRF1, a major target of the viral BGLF4 kinase. J. Gen. Virol.
89: 884-895
[Abstract]
[Full Text]
-
Xu, D., Coleman, T., Zhang, J., Fagot, A., Kotalik, C., Zhao, L., Trivedi, P., Jones, C., Zhang, L.
(2007). Epstein-Barr Virus Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication in Primary Effusion Lymphomas. J. Virol.
81: 6068-6078
[Abstract]
[Full Text]
-
Gershburg, E., Raffa, S., Torrisi, M. R., Pagano, J. S.
(2007). Epstein-Barr Virus-Encoded Protein Kinase (BGLF4) Is Involved in Production of Infectious Virus. J. Virol.
81: 5407-5412
[Abstract]
[Full Text]
-
Izumiya, Y., Izumiya, C., Van Geelen, A., Wang, D.-H., Lam, K. S., Luciw, P. A., Kung, H.-J.
(2007). Kaposi's Sarcoma-Associated Herpesvirus-Encoded Protein Kinase and Its Interaction with K-bZIP. J. Virol.
81: 1072-1082
[Abstract]
[Full Text]
-
Heston, L., El-Guindy, A., Countryman, J., Dela Cruz, C., Delecluse, H.-J., Miller, G.
(2006). Amino Acids in the Basic Domain of Epstein-Barr Virus ZEBRA Protein Play Distinct Roles in DNA Binding, Activation of Early Lytic Gene Expression, and Promotion of Viral DNA Replication.. J. Virol.
80: 9115-9133
[Abstract]
[Full Text]
-
Asai, R., Kato, A., Kato, K., Kanamori-Koyama, M., Sugimoto, K., Sairenji, T., Nishiyama, Y., Kawaguchi, Y.
(2006). Epstein-Barr Virus Protein Kinase BGLF4 Is a Virion Tegument Protein That Dissociates from Virions in a Phosphorylation-Dependent Process and Phosphorylates the Viral Immediate-Early Protein BZLF1.. J. Virol.
80: 5125-5134
[Abstract]
[Full Text]
-
Wang, J.-T., Yang, P.-W., Lee, C.-P., Han, C.-H., Tsai, C.-H., Chen, M.-R.
(2005). Detection of Epstein-Barr virus BGLF4 protein kinase in virus replication compartments and virus particles. J. Gen. Virol.
86: 3215-3225
[Abstract]
[Full Text]
-
Gershburg, E., Pagano, J. S.
(2005). Epstein-Barr virus infections: prospects for treatment. J Antimicrob Chemother
56: 277-281
[Abstract]
[Full Text]
-
Yue, W., Gershburg, E., Pagano, J. S.
(2005). Hyperphosphorylation of EBNA2 by Epstein-Barr Virus Protein Kinase Suppresses Transactivation of the LMP1 Promoter. J. Virol.
79: 5880-5885
[Abstract]
[Full Text]
-
Gonnella, R., Farina, A., Santarelli, R., Raffa, S., Feederle, R., Bei, R., Granato, M., Modesti, A., Frati, L., Delecluse, H.-J., Torrisi, M. R., Angeloni, A., Faggioni, A.
(2005). Characterization and Intracellular Localization of the Epstein-Barr Virus Protein BFLF2: Interactions with BFRF1 and with the Nuclear Lamina. J. Virol.
79: 3713-3727
[Abstract]
[Full Text]
-
Gershburg, E., Marschall, M., Hong, K., Pagano, J. S.
(2004). Expression and Localization of the Epstein-Barr Virus-Encoded Protein Kinase. J. Virol.
78: 12140-12146
[Abstract]
[Full Text]
-
Zhang, J., Das, S. C., Kotalik, C., Pattnaik, A. K., Zhang, L.
(2004). The Latent Membrane Protein 1 of Epstein-Barr Virus Establishes an Antiviral State via Induction of Interferon-stimulated Genes. J. Biol. Chem.
279: 46335-46342
[Abstract]
[Full Text]
-
Makhov, A. M., Subramanian, D., Holley-Guthrie, E., Kenney, S. C., Griffith, J. D.
(2004). The Epstein-Barr Virus Polymerase Accessory Factor BMRF1 Adopts a Ring-shaped Structure as Visualized by Electron Microscopy. J. Biol. Chem.
279: 40358-40361
[Abstract]
[Full Text]
-
Gershburg, E., Hong, K., Pagano, J. S.
(2004). Effects of Maribavir and Selected Indolocarbazoles on Epstein-Barr Virus Protein Kinase BGLF4 and on Viral Lytic Replication. Antimicrob. Agents Chemother.
48: 1900-1903
[Abstract]
[Full Text]
-
Kato, K., Yokoyama, A., Tohya, Y., Akashi, H., Nishiyama, Y., Kawaguchi, Y.
(2003). Identification of protein kinases responsible for phosphorylation of Epstein-Barr virus nuclear antigen leader protein at serine-35, which regulates its coactivator function. J. Gen. Virol.
84: 3381-3392
[Abstract]
[Full Text]
-
Williams, S. L., Hartline, C. B., Kushner, N. L., Harden, E. A., Bidanset, D. J., Drach, J. C., Townsend, L. B., Underwood, M. R., Biron, K. K., Kern, E. R.
(2003). In Vitro Activities of Benzimidazole D- and L-Ribonucleosides against Herpesviruses. Antimicrob. Agents Chemother.
47: 2186-2192
[Abstract]
[Full Text]